CardioTech needs to supply more heart bypass graft data for CE-mark
This article was originally published in Clinica
Executive Summary
Nearly a year after submitting a European market application for what could become the world's first artificial heart bypass vessel, CardioTech International has learnt that it will have to provide its notified body with additional, but "limited", clinical data.